Telemedicine Adoption, US Ambulatory Visits, and Total Medical Spending, 2019-2023

Why It Matters

The findings suggest that fears of telemedicine inflating utilization and expenditures are largely unfounded, guiding policymakers and insurers toward balanced telehealth regulations.

Key Takeaways

• Study covered 3.04 million adults, 120 million visits
• High telemedicine regions saw 2.4% fewer visits, not significant
• Spending changes under 1% across all groups, insignificant
• No utilization surge in urban, rural, or vulnerable areas
• Findings ease fears of telemedicine‑driven cost spikes

Pulse Analysis

Telemedicine’s rapid rise during the pandemic prompted lawmakers to adopt payment parity and loosen geographic restrictions, sparking a debate over whether virtual care could inflate overall health‑care utilization and costs. Critics warned that easier access might encourage unnecessary visits, while proponents argued it could improve efficiency and patient outcomes. As insurers and regulators grapple with permanent policy decisions, robust evidence on the macro‑economic impact of telehealth remains essential for shaping sustainable reimbursement frameworks.

The recent cohort study leveraged MedInsight’s national claims database, tracking 3.04 million adults across Medicare, Medicaid, and commercial plans from 2019 to 2023. Researchers compared high‑ and low‑telemedicine adoption hospital referral regions using difference‑in‑differences models, adjusting for age, sex, and diagnosis. While high‑adoption areas showed a modest 2.4% decline in total ambulatory visits and a 0.5% drop in per‑member‑per‑month spending, the 95% confidence intervals overlapped zero, indicating no statistically reliable effect. Subgroup analyses—urban versus rural, payer categories, and social vulnerability quintiles—mirrored this pattern, reinforcing the overall null result.

For policymakers, insurers, and health‑system leaders, the study offers reassurance that telemedicine expansion has not triggered a hidden surge in utilization or spending. This evidence supports maintaining payment parity and broader access without fearing runaway costs. However, the lack of significant impact also signals that telehealth alone may not drive cost savings, prompting stakeholders to explore complementary strategies—such as care coordination and value‑based contracts—to fully realize efficiency gains. Future research should monitor longer‑term trends as virtual care matures and integrates with emerging digital health tools.